SCHEMBL500789

SCHEMBL500789

Fc1cccc(B2OCc3cc(F)ccc32)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.54
CA2 P00918 3/20 0.54
PDE3A Q14432 1/20 0.54
PDE4A P27815 3/20 0.39
PDE4B Q07343 3/20 0.39
PDE4C Q08493 3/20 0.39
PDE4D Q08499 3/20 0.39
HTR7 P34969 2/20 0.32
IDO1 P14902 1/20 0.32
NISCH Q9Y2I1 1/20 0.31
CA12 O43570 2/20 0.31
CA9 Q16790 2/20 0.31
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31
HTR1A P08908 1/20 0.31
HTR1D P28221 1/20 0.31
HTR1B P28222 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
HTR2B P41595 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL500219 0.89 CA1 (0.56) CA1CA2PDE3APDE4APDE4B
SCHEMBL500064 0.88 CA1 (0.49) CA1CA2PDE3APDE4APDE4B
SCHEMBL594859 0.88 CA1 (0.42) CA1CA2PDE3APDE4APDE4B
SCHEMBL500011 0.88 CA1 (0.49) CA1CA2PDE3APDE4APDE4B
SCHEMBL10053189 0.87 CA1 (0.42) CA1CA2PDE3APDE4APDE4B
SCHEMBL500341 0.87 CA1 (0.43) CA1CA2PDE3AHTR7IDO1
SCHEMBL10053182 0.86 CA1 (0.61) CA1CA2PDE3APDE4APDE4B
SCHEMBL10053145 0.86 CA1 (0.48) CA1CA2PDE3APDE4APDE4B
SCHEMBL595765 0.86 PDE3A (0.47) CA1CA2PDE3APDE4APDE4B
SCHEMBL500067 0.85 CA1 (0.49) CA1CA2PDE3APDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240206470-A1 VOLATILE APPLICATIONS AGAINST PATHOGENS AGROFRESH INC (US) 2024-06-27 US disclosed
US-20240206470-A1 VOLATILE APPLICATIONS AGAINST PATHOGENS AGROFRESH INC (US) 2024-06-27 US disclosed
US-11771089-B2 Large-scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness AGROFRESH INC. (US) 2023-10-03 US disclosed
US-11771089-B2 Large-scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness AGROFRESH INC. (US) 2023-10-03 US disclosed
US-20220361503-A1 LARGE-SCALE METHODS OF UNIFORMLY COATING PACKAGING SURFACES WITH A VOLATILE ANTIMICROBIAL TO PRESERVE FOOD FRESHNESS ALTER DOMUS US LLC 2022-11-17 US disclosed
US-11202448-B2 Volatile applications against pathogens AGROFRESH INC. (US) 2021-12-21 US disclosed
EP-3148551-B1 VOLATILE APPLICATIONS AGAINST PATHOGENS AGROFRESH INC (US) 2021-09-29 EP disclosed
US-11039617-B2 Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness AGROFRESH INC. (US) 2021-06-22 US disclosed
US-20200296967-A1 VOLATILE APPLICATIONS AGAINST PATHOGENS ALTER DOMUS US LLC 2020-09-24 US disclosed
US-20200296966-A1 VOLATILE APPLICATIONS AGAINST PATHOGENS AGROFRESH INC (US) 2020-09-24 US disclosed
US-8106031-B2 Hydrolytically-resistant boron-containing therapeutics and methods of use ANACOR PHARMACEUTICALS, INC. (US) 2012-01-31 US disclosed
EP-2044091-A2 COMPOUNDS FOR THE TREATMENT OF PERIODONTAL DISEASE Anacor Pharmaceuticals, Inc. (US) 2009-04-08 EP disclosed
EP-2015757-A2 HYDROLYTICALLY-RESISTANT BORON-CONTAINING THERAPEUTICS AND METHODS OF USE Anacor Pharmaceuticals, Inc. (US) 2009-01-21 EP disclosed
WO-2007146965-A2 COMPOUNDS FOR THE TREATMENT OF PERIODONTAL DISEASE ANACOR PHARMACEUTICALS, INC. (US) 2007-12-21 WO disclosed
US-20070286822-A1 Compounds for the Treatment of Periodontal Disease ANACOR PHARMACEUTICALS INC. (US) 2007-12-13 US disclosed
WO-2007131072-A2 HYDROLYTICALLY-RESISTANT BORON-CONTAINING THERAPEUTICS AND METHODS OF USE ANACOR PHARMACEUTICALS, INC. (US) 2007-11-15 WO disclosed
WO-2007131072-A2 HYDROLYTICALLY-RESISTANT BORON-CONTAINING THERAPEUTICS AND METHODS OF USE ANACOR PHARMACEUTICALS, INC. (US) 2007-11-15 WO disclosed
US-20070265226-A1 Hydrolytically-Resistant Boron-Containing Therapeutics And Methods Of Use ANACOR PHARMACEUTICALS (US) 2007-11-15 US disclosed
US-20070265226-A1 Hydrolytically-Resistant Boron-Containing Therapeutics And Methods Of Use ANACOR PHARMACEUTICALS (US) 2007-11-15 US disclosed
US-20070265226-A1 Hydrolytically-Resistant Boron-Containing Therapeutics And Methods Of Use ANACOR PHARMACEUTICALS (US) 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11202448-B2 Volatile applications against pathogens OXA1L, VAPB, TIAL1 CA1 3741/4885CA2 3017/4885PDE3A 3288/4885
US-20070286822-A1 Compounds for the Treatment of Periodontal Disease BPGM, HMBS, PPIP5K2 CA1 3204/4885CA2 1752/4885PDE3A 441/4885
US-20240206470-A1 VOLATILE APPLICATIONS AGAINST PATHOGENS OXA1L, VAPB, TIAL1 CA1 3741/4885CA2 3017/4885PDE3A 3288/4885
US-11039617-B2 Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness FOSB, TAS2R10, TMBIM6 CA1 3842/4885CA2 3591/4885PDE3A 2017/4885
US-20200296966-A1 VOLATILE APPLICATIONS AGAINST PATHOGENS OXA1L, VAPB, TIAL1 CA1 3741/4885CA2 3017/4885PDE3A 3288/4885
US-11771089-B2 Large-scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness TAS2R10, FOSB, TMBIM6 CA1 3929/4885CA2 3745/4885PDE3A 2224/4885
US-20200296967-A1 VOLATILE APPLICATIONS AGAINST PATHOGENS OXA1L, VAPB, TIAL1 CA1 3741/4885CA2 3017/4885PDE3A 3288/4885
US-20070265226-A1 Hydrolytically-Resistant Boron-Containing Therapeutics And Methods Of Use GAA, BTD, MANBA CA1 838/4885CA2 535/4885PDE3A 3530/4885
US-20220361503-A1 LARGE-SCALE METHODS OF UNIFORMLY COATING PACKAGING SURFACES WITH A VOLATILE ANTIMICROBIAL TO PRESERVE FOOD FRESHNESS TAS2R10, FOSB, TMBIM6 CA1 3929/4885CA2 3745/4885PDE3A 2224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.